Skip to main content
Top
Published in: Malaria Journal 1/2009

Open Access 01-12-2009 | Research

Anti-malarial activity of 6-(8'Z-pentadecenyl)-salicylic acid from Viola websteri in mice

Authors: Ill-Min Chung, Su-Hyun Seo, Eun-Young Kang, Won-Hwan Park, Hyung-In Moon

Published in: Malaria Journal | Issue 1/2009

Login to get access

Abstract

Background

Petroleum ether extracts of Viola websteri Hemsl (Violaceae) were reported to have anti-plasmodial activity against Plasmodium falciparum in vitro, with this activity being largely attributable to 6-(8'Z-pentadecenyl)-salicylic acid (6-SA).

Methods

The schizontocidal activity of 6-SA on early Plasmodium berghei infections was evaluated in a four-day test. The possible 'repository' activity of 6-SA was assessed using the method described by Peters. The median lethal dose (LD50) of 6-SA, when given intraperitoneally, was also determined using uninfected ICR mice and the method of Lorke.

Results

In the present study, 6-SA was found to have anti-malarial activity in vivo, when tested against P. berghei in mice. 6-SA at 5, 10 and 25 mg/kg·day exhibited a significant blood schizontocidal activity in four-day early infections, repository evaluations and established infections with a significant mean survival time comparable to that of the standard drug, chloroquine (5 mg/kg·day).

Conclusion

6-SA possesses a moderate anti-malarial activity that could be exploited for malaria therapy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.CrossRefPubMed Trager W, Jensen JB: Human malaria parasites in continuous culture. Science. 1976, 193: 673-675. 10.1126/science.781840.CrossRefPubMed
2.
go back to reference Clarkson C, Maharaj VJ, Crouch NR: In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. J Ethnopharmacol. 2004, 92: 177-191. 10.1016/j.jep.2004.02.011.CrossRefPubMed Clarkson C, Maharaj VJ, Crouch NR: In vitro antiplasmodial activity of medicinal plants native to or naturalised in South Africa. J Ethnopharmacol. 2004, 92: 177-191. 10.1016/j.jep.2004.02.011.CrossRefPubMed
3.
go back to reference Biorjman A: Drug resistance: changing patterns. Malaria. Waiting for the vaccine. 1991, GAT Targett, Wiley, Chichester, 105-120. Biorjman A: Drug resistance: changing patterns. Malaria. Waiting for the vaccine. 1991, GAT Targett, Wiley, Chichester, 105-120.
4.
go back to reference Vella F, Ferry G, Delagrange P, Boutin JA: NRH: quinone reductase 2: an enzyme of surprises and mysteries. Biochemical Pharmacol. 2005, 71: 1-12. 10.1016/j.bcp.2005.09.019.CrossRef Vella F, Ferry G, Delagrange P, Boutin JA: NRH: quinone reductase 2: an enzyme of surprises and mysteries. Biochemical Pharmacol. 2005, 71: 1-12. 10.1016/j.bcp.2005.09.019.CrossRef
5.
go back to reference Lindholm P, Goransson U, Johansson S: Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther. 2002, 1: 365-369.PubMed Lindholm P, Goransson U, Johansson S: Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther. 2002, 1: 365-369.PubMed
6.
go back to reference Moon HI, Jung JC, Lee J: Antiplasmodial activity of triterpenoid isolated from whole plants of Viola genus from South Korea. Parasitol Res. 2007, 100: 641-644. 10.1007/s00436-006-0279-8.CrossRefPubMed Moon HI, Jung JC, Lee J: Antiplasmodial activity of triterpenoid isolated from whole plants of Viola genus from South Korea. Parasitol Res. 2007, 100: 641-644. 10.1007/s00436-006-0279-8.CrossRefPubMed
7.
go back to reference Lee SJ, Park WH, Moon HI: Bioassay-guided isolation of antiplasmodial anacardic acids derivatives from the whole plants of Viola websteri Hemsl. Parasitol Res. 2009, 104: 463-466. 10.1007/s00436-008-1205-z.CrossRefPubMed Lee SJ, Park WH, Moon HI: Bioassay-guided isolation of antiplasmodial anacardic acids derivatives from the whole plants of Viola websteri Hemsl. Parasitol Res. 2009, 104: 463-466. 10.1007/s00436-008-1205-z.CrossRefPubMed
8.
go back to reference Lorke D: A new approach to practical acute toxicity testing. Arch Toxicol. 1983, 54: 275-287. 10.1007/BF01234480.CrossRefPubMed Lorke D: A new approach to practical acute toxicity testing. Arch Toxicol. 1983, 54: 275-287. 10.1007/BF01234480.CrossRefPubMed
9.
go back to reference Knight DJ, Peters W: The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol. 1980, 74: 393-404.PubMed Knight DJ, Peters W: The antimalarial activity of N-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action. Ann Trop Med Parasitol. 1980, 74: 393-404.PubMed
10.
go back to reference Peters W: Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance. Exp Parasitol. 1965, 17: 80-89. 10.1016/0014-4894(65)90012-3.CrossRefPubMed Peters W: Drug resistance in Plasmodium berghei Vincke and Lips, 1948. I. Chloroquine resistance. Exp Parasitol. 1965, 17: 80-89. 10.1016/0014-4894(65)90012-3.CrossRefPubMed
11.
go back to reference Ryley JF, Peters W: The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol. 1970, 64 (2): 209-222.PubMed Ryley JF, Peters W: The antimalarial activity of some quinolone esters. Ann Trop Med Parasitol. 1970, 64 (2): 209-222.PubMed
Metadata
Title
Anti-malarial activity of 6-(8'Z-pentadecenyl)-salicylic acid from Viola websteri in mice
Authors
Ill-Min Chung
Su-Hyun Seo
Eun-Young Kang
Won-Hwan Park
Hyung-In Moon
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2009
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-8-151

Other articles of this Issue 1/2009

Malaria Journal 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.